PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer
Oncology Research · 2026
DOI: 10.32604/or.2026.081209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Zhengzheng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Phosphoglycerate Kinase, Triple Negative Breast Neoplasms, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies. Phosphoglycerate kinase 1 (PGK1) drives TNBC progression, but mechanisms governing its protein stability remain unclear. This study aims to identify the E3 ubiquitin ligase responsible for PGK1 degradation and evaluate its therapeutic potential against metastasis.
Methods
Clinical datasets and 50 human TNBC tissues were analyzed via multiplex immunohistochemistry. Co-immunoprecipitation, ubiquitination linkage assays, and structural modeling were utilized for in vitro mechanistic studies in TNBC cells. Additionally, functional impacts on epithelial-mesenchymal transition (EMT) and metastasis were evaluated using transwell assays and an in vivo mouse lung metastasis model.
Results
Parkinson disease protein 2 (PARK2) is a novel E3 ubiquitin ligase that mediates proteasomal degradation of PGK1 in TNBC cells. Elevated PGK1 expression and reduced PARK2 expression in TNBC, with high PGK1 levels correlating with unfavorable overall survival (HR: 2.138, 95%CI:1.001 to 4.569, p = 0.049). PARK2 physically binds PGK1 via its RING2 domain and promotes K48-linked polyubiquitination, leading to proteasomal degradation. A significant negative correlation between PARK2 and PGK1 at the protein levels were confirmed in 50 TNBC tumor tissues (Spearman's rho = -0.58, p < 0.001). Functionally, PARK2 overexpression reduced mesenchymal markers (Vimentin, Snail1, Slug) and suppressed migration and invasion of TNBC cells, effects that were reversed by PGK1 overexpression. PARK2 significantly inhibited PGK1-mediated lung metastasis in in vivo tail vein injection models Conclusion: These findings establish the PARK2-PGK1 axis as a critical regulator of partial epithelial-mesenchymal transition and metastasis in TNBC, suggesting that strategies to enhance PARK2 expression or activity may represent promising therapeutic approaches for this aggressive breast cancer subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Breast Center, West China Hospital, Sichuan University, Chengdu, China.
- Breast Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
- Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Li, Z., Xie, H., Chen, Y., Li, Q., Yuan, X., Dai, X., & Chen, J. (2026). PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer. Oncology Research. https://doi.org/10.32604/or.2026.081209
Vancouver
Li Z, Xie H, Chen Y, Li Q, Yuan X, Dai X, et al. PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer. Oncology Research. 2026. doi:10.32604/or.2026.081209
BibTeX
@article{Li2026,
author = {Li, Zhengzheng and Xie, Haitong and Chen, Yujuan and Li, Qiuyan and Yuan, Xing and Dai, Xinyue and Chen, Jie},
title = {PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.081209}
}
EUVIMED